Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Gilead, US FDA Ponder Innovative Designs For Descovy HIV Prevention Study In Women
Aug 12 2019
•
By
Sue Sutter
Gilead and the FDA are trying to solve the problem of how to study Truvada's successor, Descovy, for PrEP in cisgender women. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers